HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SOLS

Solstice Advanced Materials, Inc. (NASDAQ)

Basic Materials — Specialty Chemicals

Solstice Advanced Materials, Inc. operates as a specialty chemicals and advanced materials company in the United States and internationally. It operates in two segments: Refrigerants & Applied Solutions (RAS), and Electronic & Specialty Materials (ESM). The RAS segment manufactures and sells low global warming potential (LGWP) refrigerants, blowing agents, solvents, and aerosol materials; and provides, aerosol propellants, cleaning solvents, pharmaceutical packaging materials, and alternative energy services under the Solstice, Genetron, and Aclar brands. The ESM segment offers electronic materials, fibers and laboratory life science chemicals for semiconductor, defense, pharmaceutical, and construction markets. This segment provides sputtering targets, lightweight high-strength fibers, and high-purity life science solutions under the Spectra, Fluka, and Hydranal brands. Solstice Advanced Materials, Inc. was incorporated in 2025 and is headquartered in Morris Plains, New Jersey.

Hold 2.6 / 5 7 analysts
$60.67
+$0.59 (+0.98%)
Target: $92.29 (52.1%)
Sign in to add SOLS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$13.23B
P/E Ratio (TTM)70.01
Forward P/E26.15
EPS (TTM)$1.19
Dividend Yield0.36%
Profit Margin4.72%
Revenue Growth10.60%
ROE10.74%
Debt/Equity165.22
Recommendation Hold 2.6
Analyst Target$92.29
Analysts7
Indexes NASDAQ

Technical Indicators

RSI (14)53.3
Beta-
SMA 20-
SMA 40-
52-Week High$90.80
52-Week Low$40.43
50-Day Avg$83.12
200-Day Avg$67.31
Avg Volume$2.77M
Volume$3.29M

Performance Analysis

NEUTRAL

SOLS presents a mixed picture with both positive and negative indicators.

~ Trading at 40% of its 52-week range.
~ RSI at 53.3 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- P/E of 70.0 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 10.6% year-over-year.
~ Wall Street consensus is "Hold" from 7 analysts.
+ Average analyst target of $92.29 implies 52.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:32 UTC

Back to Screener Export Report